PC
Pacira BioSciences, Inc.
PCRX · NASDAQ
$25.56 +3.99% (+$0.98)
1M -3.53%
Market Cap $968.8M
P/E Ratio 66.19x
Div. Yield -
ROE 2.13%
Bulios Fair Price
$25.33
0.9% downside
Trenutna cena
$25.56
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica PCRX trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
70 /100
Cheap EV/EBITDA 10.24x
P/S 1.30x
P/B 1.44x
Growth
25 /100
Declining Rev. growth 2.89%
FCF growth 5.86%
Book val. growth 3.65%
Profitability
57 /100
Moderate Net margin 1.96%
Op. margin 2.47%
FCF margin 24.06%
Quality
13 /100
Poor ROE 2.13%
ROA 1.18%
Asset turnover 0.60x
Debt
66 /100
Moderate Current ratio 5.04x
Int. coverage 2.14x
Net debt/EBITDA 1.80x
Stability
37 /100
Moderate Rev. volatility 1.46%
EPS volatility 276.26%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PCRX
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Frank D. Lee
Employees
827
Headquarters
Brisbane
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report